R. Stupp, W. Mason, M. Van-den-bent, M. Weller, B. Fisher et al., Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005.
DOI : 10.1056/NEJMoa043330

G. Minniti, D. Amelio, M. Amichetti, M. Salvati, R. Muni et al., Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide, Radiotherapy and Oncology, vol.97, issue.3, pp.377-381, 2010.
DOI : 10.1016/j.radonc.2010.08.020

A. Monjazeb, D. Ayala, C. Jensen, L. Case, J. Bourland et al., A Phase I Dose Escalation Study of Hypofractionated IMRT Field-in-Field Boost for Newly Diagnosed Glioblastoma Multiforme, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.2, pp.743-748, 2012.
DOI : 10.1016/j.ijrobp.2010.10.018

D. Amelio, S. Lorentini, M. Schwarz, and M. Amichetti, Intensity-modulated radiation therapy in newly diagnosed glioblastoma: A systematic review on clinical and technical issues, Radiotherapy and Oncology, vol.97, issue.3, pp.361-369, 2010.
DOI : 10.1016/j.radonc.2010.08.018

J. Chan, S. Lee, B. Fraass, D. Normolle, H. Greenberg et al., Survival and Failure Patterns of High-Grade Gliomas After Three-Dimensional Conformal Radiotherapy, Journal of Clinical Oncology, vol.20, issue.6, pp.1635-1642, 2002.
DOI : 10.1200/JCO.2002.20.6.1635

K. Kallen, I. Burtscher, S. Holtas, and E. Ryding, Rosen I: 201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas, Journal of Neuro-Oncology, vol.46, issue.2, pp.173-185, 2000.
DOI : 10.1023/A:1006429329677

C. Tsien, D. Brown, D. Normolle, M. Schipper, P. Morand et al., Concurrent Temozolomide and Dose-Escalated Intensity-Modulated Radiation Therapy in Newly Diagnosed Glioblastoma, Clinical Cancer Research, vol.18, issue.1, pp.273-279, 2012.
DOI : 10.1158/1078-0432.CCR-11-2073

J. Alger, J. Frank, A. Bizzi, M. Fulham, B. Desouza et al., Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET., Radiology, vol.177, issue.3, pp.633-641, 1990.
DOI : 10.1148/radiology.177.3.2243962

C. Dowling, A. Bollen, S. Noworolski, M. Mcdermott, N. Barbaro et al., Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens, AJNR Am J Neuroradiol, vol.22, pp.604-612, 2001.

A. Tzika, Proton magnetic resonance spectroscopic imaging as a cancer biomarker for pediatric brain tumors (Review), international Journal of Oncology, vol.32, issue.3, pp.517-526, 2008.
DOI : 10.3892/ijo_32_3_517

L. Astrakas, D. Zurakowski, A. Tzika, M. Zarifi, D. Anthony et al., Noninvasive Magnetic Resonance Spectroscopic Imaging Biomarkers to Predict the Clinical Grade of Pediatric Brain Tumors, Clinical Cancer Research, vol.10, issue.24, pp.8220-8228, 2004.
DOI : 10.1158/1078-0432.CCR-04-0603

A. Pirzkall, X. Li, J. Oh, S. Chang, M. Berger et al., 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI, International Journal of Radiation Oncology*Biology*Physics, vol.59, issue.1, pp.126-137, 2004.
DOI : 10.1016/j.ijrobp.2003.08.023

F. Crawford, I. Khayal, C. Mcgue, S. Saraswathy, A. Pirzkall et al., Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM, Journal of Neuro-Oncology, vol.1, issue.3, pp.337-351, 2009.
DOI : 10.1007/s11060-008-9719-x

S. Saraswathy, F. Crawford, K. Lamborn, A. Pirzkall, S. Chang et al., Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy, Journal of Neuro-Oncology, vol.71, issue.1, pp.69-81, 2009.
DOI : 10.1007/s11060-008-9685-3

T. Sankar, Z. Caramanos, R. Assina, J. Villemure, R. Leblanc et al., Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma, Journal of Neuro-Oncology, vol.61, issue.1, pp.63-76, 2008.
DOI : 10.1007/s11060-008-9632-3

T. Mcknight, M. Dem-bussche, D. Vigneron, Y. Lu, M. Berger et al., Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence, Journal of Neurosurgery, vol.97, issue.4, pp.794-802, 2002.
DOI : 10.3171/jns.2002.97.4.0794

I. Park, G. Tamai, M. Lee, C. Chuang, S. Chang et al., Patterns of Recurrence Analysis in Newly Diagnosed Glioblastoma Multiforme After Three-Dimensional Conformal Radiation Therapy With Respect to Pre???Radiation Therapy Magnetic Resonance Spectroscopic Findings, International Journal of Radiation Oncology*Biology*Physics, vol.69, issue.2, pp.381-389, 2007.
DOI : 10.1016/j.ijrobp.2007.03.019

Q. Zeng, C. Li, H. Liu, J. Zhen, and D. Feng, Distinction Between Recurrent Glioma and Radiation Injury Using Magnetic Resonance Spectroscopy in Combination With Diffusion-Weighted Imaging, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.1, pp.151-158, 2007.
DOI : 10.1016/j.ijrobp.2006.12.001

E. Moyal, A. Laprie, M. Delannes, M. Poublanc, I. Catalaa et al., Phase I Trial of Tipifarnib (R115777) Concurrent With Radiotherapy in Patients with Glioblastoma Multiforme, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.5, pp.1396-1401, 2007.
DOI : 10.1016/j.ijrobp.2007.02.043

A. Laprie, I. Catalaa, E. Cassol, T. Mcknight, D. Berchery et al., Proton Magnetic Resonance Spectroscopic Imaging in Newly Diagnosed Glioblastoma: Predictive Value for the Site of Postradiotherapy Relapse in a Prospective Longitudinal Study, International Journal of Radiation Oncology*Biology*Physics, vol.70, issue.3, pp.773-781, 2008.
DOI : 10.1016/j.ijrobp.2007.10.039

S. Bentzen and V. Gregoire, Molecular Imaging???Based Dose Painting: A Novel Paradigm for Radiation Therapy Prescription, Seminars in Radiation Oncology, vol.21, issue.2, pp.101-110, 2011.
DOI : 10.1016/j.semradonc.2010.10.001

G. Meijer, J. Steenhuijsen, M. Bal, D. Jaeger, K. Schuring et al., Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: Practical implications of using a broad or sharp brush, Radiotherapy and Oncology, vol.100, issue.3, pp.396-401, 2011.
DOI : 10.1016/j.radonc.2011.08.048

Y. Zhang, J. Chu, W. Hsi, A. Khan, P. Mehta et al., Evaluation of Four Volume-Based Image Registration Algorithms, Medical Dosimetry, vol.34, issue.4, pp.317-322, 2009.
DOI : 10.1016/j.meddos.2008.12.004

B. Jones and P. Sanghera, Estimation of Radiobiologic Parameters and Equivalent Radiation Dose of Cytotoxic Chemotherapy in Malignant Glioma, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.2, pp.441-448, 2007.
DOI : 10.1016/j.ijrobp.2006.12.025

N. Lomax and S. Scheib, Quantifying the degree of conformity in radiosurgery treatment planning, International Journal of Radiation Oncology*Biology*Physics, vol.55, issue.5, pp.1409-1419, 2003.
DOI : 10.1016/S0360-3016(02)04599-6

A. Smith, Color gamut tranform pairs, SIGGRAPH 78 Conference Proceedings, pp.12-19, 1978.
DOI : 10.1145/800248.807361

M. Piroth, M. Pinkawa, R. Holy, J. Klotz, S. Schaar et al., Integrated-Boost-IMRT mit FET-PET-adaptierter lokaler Dosiseskalation beim Glioblastom, Strahlentherapie und Onkologie, vol.25, issue.4, pp.334-339, 2012.
DOI : 10.1007/s00066-011-0060-5

A. Morganti, M. Balducci, M. Salvati, V. Esposito, P. Romanelli et al., A Phase I Dose-Escalation Study (ISIDE-BT-1) of Accelerated IMRT With Temozolomide in Patients With Glioblastoma, International Journal of Radiation Oncology*Biology*Physics, vol.77, issue.1
DOI : 10.1016/j.ijrobp.2009.04.064

J. Watkins, D. Marshall, S. Patel, P. Giglio, A. Herrin et al., High-dose radiotherapy to 78??Gy with or without temozolomide for high grade gliomas, Journal of Neuro-Oncology, vol.359, issue.suppl 1, pp.343-348, 2009.
DOI : 10.1007/s11060-008-9779-y

M. Terasaki, T. Eto, S. Nakashima, Y. Okada, E. Ogo et al., A pilot study of hypofractionated radiation therapy with temozolomide for adults with glioblastoma multiforme, Journal of Neuro-Oncology, vol.21, issue.2, pp.247-253, 2011.
DOI : 10.1007/s11060-010-0306-6

A. Narayana, J. Chang, S. Thakur, W. Huang, S. Karimi et al., Use of MR spectroscopy and functional imaging in the treatment planning of gliomas, The British Journal of Radiology, vol.80, issue.953, pp.347-354, 2007.
DOI : 10.1259/bjr/65349468

J. Chang, S. Thakur, W. Huang, and A. Narayana, Magnetic resonance spectroscopy imaging (MRSI) and brain functional magnetic resonance imaging (FMRI) for radiotherapy treatment planning of glioma, Technol Cancer Res Treat, vol.7, pp.349-362, 2008.

A. Stadlbauer, E. Moser, S. Gruber, C. Nimsky, R. Fahlbusch et al., Integration of biochemical images of a tumor into frameless stereotaxy achieved using a magnetic resonance imaging/magnetic resonance spectroscopy hybrid data set, Journal of Neurosurgery, vol.101, issue.2, pp.287-294, 2004.
DOI : 10.3171/jns.2004.101.2.0287

D. Wagner, H. Christiansen, H. Wolff, and H. Vorwerk, Radiotherapy of malignant gliomas: Comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique, Radiotherapy and Oncology, vol.93, issue.3, pp.593-596, 2009.
DOI : 10.1016/j.radonc.2009.10.002

L. Douw, M. Klein, S. Fagel, H. V. Den, M. Taphoorn et al., Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up, The Lancet Neurology, vol.8, issue.9, pp.810-818, 2009.
DOI : 10.1016/S1474-4422(09)70204-2